Vaccine sceptic Novak Djokovic holds major stakes in a firm developing Covid drug, says CEO

Updated : Jan 20, 2022 09:37
|
Editorji News Desk

Covid vaccine sceptic Novak Djokovic who bore the brunt of his denial after he was sent back from Australia holds major stakes in a firm developing Covid-19 drugs, confirmed the Danish Company's CEO. 

Also Read Premier League: Marcus Rashford ends goal drought as Man United beat Brentford 3-1

He is one of the founders of my company, which we founded in June 2020, the CEO of QuantBioRes Ivan Loncarevic said on Wednesday. As per the information available publicly, the 20-time Grand Slam Champion who missed his chance at the ongoing Australian Open due to the vaccination row holds 80% stakes in the company along with his wife Jelena. 

Loncarevic informed that his company is working for drugs against different viruses and are using Covid as a showcase. 

The 9+time Australian Open Champion had a dramatic start to the year after the Australian government denied his entry in Melbourne due to his vaccination status. The World no. 1 was sent back just before the start of the first Grand Slam of the year.  

AUS OPENNovak DjokovicGrand slam

Recommended For You

editorji | Sports

Ravichandran Ashwin's fun time with support staff reminisced by BCCI | Watch

editorji | Sports

\'Mereko marwaoge\': Rohit Sharma's hilarious response to Pujara, Rahane 'retirement mistake' goes viral

editorji | Sports

Ravichandran Ashwin retires: Cricket world pays tribute to all-time great

editorji | Sports

India vs Australia: Travis Head confident he'll be 'fine' for Boxing Day Test

editorji | Sports

Ravichandran Ashwin retires: Leaves legacy as 7th highest Test wicket-taker